Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single nucleotide polymorphisms and their characterization with oligonucleotide microarrays.

Dennise D Dalma-Weiszhausz1, Greer M Murphy

  • 1Affymetrix, Santa Clara, California 95051, USA. dennisedalma@affymetrix.com

Psychiatric Genetics
|July 20, 2002
PubMed
Summary

Genetic variations impact disease risk and medication response. Understanding these DNA changes, particularly in psychiatric disorders, is key to developing personalized treatments and improving drug efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression.

Translational psychiatry·2018
Same author

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

The American journal of psychiatry·2015
Same author

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2015
Same author

APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.

Neurobiology of aging·2014
Same author

BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.

Pharmacogenetics and genomics·2013
Same author

Influences of APOE ε4 and expertise on performance of older pilots.

Psychology and aging·2011

Area of Science:

  • Genetics
  • Pharmacogenomics
  • Neuropsychiatry

Background:

  • Human DNA sequence variations influence disease susceptibility and drug responses.
  • Many psychiatric diseases are polygenic, involving multiple genes.
  • Current molecular understanding of neuropsychiatric disorder genetic causes is limited.

Purpose of the Study:

  • To highlight the importance of discovering and characterizing genetic variations.
  • To explore the potential for genotype-guided personalized medicine in psychiatry.
  • To discuss advancements in genotyping technologies for psychiatric research.

Main Methods:

  • Review of conventional genotyping methods.
  • Discussion of new and emerging technologies for single nucleotide polymorphism (SNP) characterization.

Related Experiment Videos

  • Focus on applications in psychiatric diseases and medication response.

    • Main Results:

    • Genetic variations play a significant role in disease predisposition.
    • Understanding genetic variations can guide the selection of psychiatric medications.
    • Technological advancements are improving the characterization of genetic markers.

    Conclusions:

    • Characterizing genetic variations is crucial for identifying disease genes in neuropsychiatric disorders.
    • Personalized drug selection based on individual genotypes can optimize treatment efficacy and minimize adverse effects.
    • Continued research into genetic variations and genotyping technologies will advance psychiatric pharmacogenomics.